On the other hand, pBPB is PLA2 inhibitor and PLA2 may activate fibrosis via the arginase/TGF-β pathway [21,22], therefore we hypothesized that pBPB may attenuate certain features of pulmonary fibrosis. This evidence concerns the gene PLA2G2A and pulmonary fibrosis.